Cancer Genomics Clinical Trials Fund: SCCT Program

Overview

The Cancer Genomics Clinical Trials Fund (the Fund) is a one-off grant opportunity that will run over three years, FY2025-26 through to FY2027-28. The Fund will direct additional investment to Australia's Multi-site Collaborative Cancer Clinical Trials Groups (CTGs) under the Support for Cancer Clinical Trials (SCCT) program to build capacity and develop approached of methods to set the foundation for, and accelerate the incorporation of genomics into the design of cancer clinical trial concepts and protocols to benefit all CTGs.  For further information please refer to the Cancer Genomics Clinical Trials Fund Grant Opportunity Guidelines.